Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

GUD.TO Relative to the S&P 500

GUD.TO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Knight Therapeutics Inc. (TSE:GUD.TO) seasonal charts above shows that a Buy Date of December 12 and a Sell Date of May 3 has resulted in a geometric average return of 1.26% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 14.25% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montr al, Canada.

To download GUD.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: GUD.TO